Advertisement

Pearson

Bausch Health: an ex-sinner to buy now
Michael Pearson © Andrew Harrer/Bloomberg via Getty Images
Share tips

Bausch Health: an ex-sinner to buy now

Pharmaceutical firm Bausch Health, formerly known as Valeant, is putting a dodgy past behind it.
13 Aug 2019
Three laggards to buy for long-term growth
Share tips

Three laggards to buy for long-term growth

Some of the best long-term capital-growth opportunities lie in companies that have struggled over the past few years, says professional investor Ben R…
8 Apr 2016
The smart money is backing print – so why is Pearson flogging The Economist?
755-economist-634
UK Economy

The smart money is backing print – so why is Pearson flogging The Economist?

In selling The Economist, Pearson might well be flogging the wrong assets at the wrong time, says Matthew Lynn.
16 Aug 2015
Advertisement